首页> 美国卫生研究院文献>Yonago Acta Medica >Contrast-Enhanced Ultrasonography in Evaluation of the Therapeutic Effect of Chemotherapy for Patients with Liver Metastases
【2h】

Contrast-Enhanced Ultrasonography in Evaluation of the Therapeutic Effect of Chemotherapy for Patients with Liver Metastases

机译:超声造影评价肝癌患者化疗的疗效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe therapeutic effect of chemotherapy for liver metastases is currently determined by changes in tumor diameter depicted on computed tomography (CT) and magnetic resonance imaging, but it cannot accurately determine if there is central necrosis. Furthermore, due to the risk of radiation exposure and high cost, frequent examination using these methods places a heavy burden on patients. Meanwhile, real-time observation of blood flow and vessel morphology within tumors has become possible by contrast-enhanced ultrasonography (CEUS). However, use of CEUS in evaluating the therapeutic effect of anticancer chemotherapy has rarely been investigated. This study investigated whether changes in the time-intensity curve (TIC) of CEUS are useful indicators of the therapeutic effect of chemotherapy.
机译:背景技术目前,通过计算机断层扫描(CT)和磁共振成像所描绘的肿瘤直径变化来确定化学疗法对肝转移的治疗效果,但是它不能准确地确定是否存在中央坏死。此外,由于暴露于放射线的风险和高成本,使用这些方法的频繁检查给患者带来沉重负担。同时,通过超声造影(CEUS)可以实时观察肿瘤内的血流和血管形态。但是,很少研究使用CEUS评估抗癌化疗的疗效。这项研究调查了CEUS时间强度曲线(TIC)的变化是否是化学疗法治疗效果的有用指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号